gene_name
string | gene_id
string | category
string | cell_name
string | tissue_type
string | phenotype
string | aging_type
string | experiment
string | description
string | target_gene
string | regulatory_type_of_target_gene
string | target_gene_experiment
string | target_gene_description
string | regulatory_pathway
string | regulatory_type_of_pathway
string | pathway_experiment
string | pathway_description
string | species
string | experimental_category
string | aging_characteristic
string | pmid
int64 | source
string | Alizarin_red_S_staining
int64 | Annexin_V_binding_assay
int64 | Apoptosis_assay
int64 | Atomic_force_microscopy_imaging
int64 | Autofluorescence
int64 | Behavioral_assessment
int64 | BrdU_analysis
int64 | BrdU_assay
int64 | CCK_8_assay
int64 | CHIP
int64 | Cell_activity_assay
int64 | Cell_apoptosis_assay
int64 | Cell_counting
int64 | Cell_cycle_analysis
int64 | Cell_growth_assay
int64 | Cell_migration_assay
int64 | Cell_morphological_analysis
int64 | Cell_proliferation_assay
int64 | Cell_transfection
int64 | Cell_viability_assay
int64 | ChIP_qPCR
int64 | Clonal_expansion_assay
int64 | Clonogenic_assay
int64 | Colony_formation_assay
int64 | Colony_formation?assay
int64 | Comet_assay
int64 | Crystal_violet_assay
int64 | Cytokine_assay
int64 | DAPI_staining
int64 | DNA_FISH
int64 | DNA_fiber_assay
int64 | ELISA
int64 | EdU_Assay
int64 | EdU_assay
int64 | EdU_assay/SA__gal_activity_assay
int64 | EdU_cell_proliferation_assay
int64 | FACS_analysis
int64 | FCM_analysis
int64 | FISH
int64 | FITC_Annexin_V/PI
int64 | Flow_cyotmetry
int64 | Flow_cytometry
int64 | Fluorescence_quenching_assay
int64 | GO_analysis
int64 | GSEA_analysis
int64 | Giemsa_staining
int64 | Growth_curve_assay
int64 | Growth_kinetics_analysis
int64 | Histochemical_staining
int64 | Histological_images_analysis
int64 | Histological_staining
int64 | Hoechst_staining
int64 | IHC
int64 | IHC_staining
int64 | Immunoblotting
int64 | Immunochemical_staining
int64 | Immunocytochemistry
int64 | Immunofluorescence
int64 | Immunohistochemical_staining
int64 | Immunohistochemistry
int64 | Immunostaining
int64 | Immunostainings
int64 | JC_1_probe_staining
int64 | Ki67_staining
int64 | Knockdown
int64 | LDH_activity_assay
int64 | Lifespan_assay
int64 | Luciferase_reporter_assay
int64 | MTS_assay
int64 | MTT_assay
int64 | Microarray
int64 | Northern_blot
int64 | PCR
int64 | PI_staining
int64 | Prevent
int64 | RNA_seq
int64 | ROS_assay
int64 | ROS_staining
int64 | RT__PCR
int64 | RT_PCR
int64 | RT_qPCR
int64 | SA__Gal_activity_assay
int64 | SA__gal_activity
int64 | SA__gal_activity_assay
int64 | SA__gal_staining
int64 | SAHF
int64 | Safranin_O_fast_green_staining
int64 | Safranin_O/Fast_Green_staining
int64 | Safranin_O
int64 | Southern_Blot
int64 | Southern_blot
int64 | Southern_blot_analysis
int64 | Southern_hybridization
int64 | Southern_hybridization_analysis
int64 | Survival_curve
int64 | TRAP_assay
int64 | TRF_analysis
int64 | TRF_assay
int64 | TUNEL_assay
int64 | Telomerase_Assay
int64 | Telomerase_activity_assay
int64 | Telomerase_assay
int64 | Telomere_length_assay
int64 | Transmission_electron_microscopy
int64 | Transwell_assay
int64 | Trypan_blue_staining
int64 | Tube_formation_assay
int64 | WST_1_assay
int64 | WST_8_assay
int64 | Western_blot
int64 | XTT_assay
int64 | miRNA_qRT_PCR
int64 | qPCR
int64 | qPT_PCR
int64 | qRT_PCR
int64 | qRT¨CPCR
int64 | ¦ÃH2AX_staining
int64 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SIRT1
|
23411
|
protein coding
|
BM-MSC
|
--
|
Osteoporosis
|
Prevent
|
BrdU assay//Colony formation assay//SA--gal activity assay//Western blot
|
Compared with cells from the vehicle-treated group, resveratrol-treated cells had a higher percentage of BrdU positive cells and numbers of ALP+ CFU-f colonies. Resveratrol-treated M-MSCs from WT mice had similar numbers of ALP+ CFU-f colonies as vehicle treated M-MSCs from Sirt1TG mice, and resveratrol-treated M-MSCs from Sirt1TG mice had the highest numbers of ALP+ CFU-f colonies.Consistent with these results, p16 expression levels and senescence associated ¦Â-Gal positive areas were increased in H-BM-MSCs from old people and decreased in response to resveratrol, and these changes were blocked by the Sirt1-specific knockdown virus.
|
Bmi1
|
Binding
|
Western blot//IP
|
The results showed that Sirt1 could bind to Bmi1.Immunoprecipitation with an anti-Bmi1 antibody showed a dose-dependent upregulation of Sirt1 protein expression associated with decreased expression of acetylated lysine. Western blot data from nuclear lysates demonstrated that the dose-dependent upregulation of Sirt1 was concomitant with the upregulation of Bmi1 expression.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 30,690,778 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAMPT
|
10135
|
protein coding
|
IMR-90
|
--
|
Aging
|
Accelerate
|
Immunostaining//Knockdown//SA--gal activity assay
|
Inhibition of NAMPT by knockdown or by treatment with the small-molecule inhibitor FK86619 suppressed RAS-induced senescence at the time of initiation. Notably, NAMPT upregulation coincided with the upregulation of genes in the second, proinflammatory, SASP wave such as IL1B, IL6 and IL8.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 30,778,219 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
KDM4A
|
9682
|
protein coding
|
IMR-90
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay
|
Compared to cells transfected with siGFP, cells depleted of JMJD2A exhibited a flattened vacuolated morphology accompanied by a positive staining to the senescence-associated ¦Â-galactosidase assay(SA-¦Â-gal).However, the knockdown of JMJD2A led to the accumulation of PML nuclear bodies,another well- characterized senescence marker.
|
CHD5
|
Binding
|
CHIP//qRT-PCR//Knockdown
|
Among the two putative JMJD2A-binding sites identified by ChIP-on-chip on the CHD5 promoter, only the site located at +741 was enriched by ChIP-qPCR.JMJD2A depletion also led to a concomitant increase of CHD5 mRNA and protein.We detected an increase of H3K9(me3) levels at the CHD5 promoter after depletion of JMJD2A .
|
p53
|
Downregulation
|
SA-¦Â-gal activity assay//Knockdown
|
Transfection of siRNAs targeting JMJD2A triggered senescence in p16-depleted cells but not in p53-depleted cells, suggesting that the senescence response triggered by decreased JMJD2A levels relies primarily on the p53 pathway. Ectopic expression of JMJD2A caused a significant decrease of both p53 and p21 in Ras-expressing cells.
|
Human
|
L
|
delay aging
| 23,168,260 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ABCC3
|
8714
|
protein coding
|
HEC-TR
|
--
|
Aging
|
Accelerate
|
Cell morphological analysis//SA--gal activity assay//qRT-PCR
|
This ABCC3-induced proliferation reduction was linked to senescence induction, as cells at p2 postinfection adopted the distinctive enlarged morphology of senescent cells and displayed both increased SA-¦ÂGal activity and induction of IL8 expression.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 26,073,088 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
PIK3CA
|
5290
|
protein coding
|
MCF 10A/H
|
--
|
Breast cancer
|
Accelerate
|
Cell morphological analysis//SA--gal activity assay
|
Unexpectedly, we found that MCF-10A/H cells exhibited a significant increase in cell size after 96-h serum-starvation, which was accompanied with flat and enlarged morphology, suggesting cellular senescence might be induced in serum-starved MCF-10A/H cells. The fraction of SA-¦Â-gal-positive cells increased with the duration of serum-starvation and nearly 80% of cell population under-went senescence after cells were serum-depleted for 96 h .GDC0941, a pan inhibitor of class I PI3K, significantly abrogated the induction of senescence represented by decreased SA-¦Â-gal-positive cells.
|
MME
|
Upregulation
|
SA-¦Â-gal activity assay//Knockdown//RT-PCR//Western blot
|
The cluster analysis showed that the mRNA level of membrane metallo-endopeptidase (MME) increased in MCF-10A/H cells compared to parental cells and the up-regulation was further enhanced when MCF-10A/H cells were serum-starved. Induction of MME was confirmed at both RNA and protein levels in serum-deprived MCF-10A/H cells. Moreover, knock-down of MME significantly blocked the induction of senescence in serum-starved MCF-10A/H cells.
|
PI3K-Akt-mTOR
|
--
|
SA-¦Â-gal activity assay//Western blot//Knockdown//qRT-PCR
|
GDC0941, a pan inhibitor of class I PI3K, significantly abrogated the induction of senescence represented by decreased SA-¦Â-gal-positive cells, which was consistent with the down-regulation of phosphorylated AKT at S473. Similar results were obtained with A66, a PI3K¦Á-selective inhibitor, which was consistent with the observation that knocking down of p110¦Á alone was able to block the induction of senescence.As AKT is the major downstream effector of PI3K signaling, we treated serum-starved MCF-10A/H cells with GSK690693, an ATP-competitive inhibitor, or MK2206, an allosteric inhibitor. Both compounds prevented the induction of senescence at concentration range that inhibited AKT activity demonstrated by phosphorylated PRAS40.
|
Human
|
HL
|
delay aging
| 30,671,946 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ATF1
|
466
|
protein coding
|
Sarcoma-iPSC MEF
|
--
|
Clear cell sarcoma
|
Accelerate
|
Cell morphological analysis//RT-PCR//SA--gal activity assay
|
EWS/ATF1-expressing sarcoma-iPSC MEFs ceased growth and changed morphology into a large and flat shape.The senescenceassociated ¦Â galactosidase (SA ¦Â-gal)-positive cell ratio was significantly higher in EWS/ATF1-expressing MEFs than in non-expressing MEFs,suggesting that EWS/ATF1 induces premature senescence in sarcoma-iPSC MEFs.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 31,488,818 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SERTAD1
|
29950
|
protein coding
|
MCF-7
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay
|
The SLP induced by doxorubicin was not observed in p34SEI-1¨C expressing MCF7 cells. Furthermore, the levels of various cytoplasmic marker proteins such as fibronectin and promyelocytic leukemia, which specifically decreases in senescent cells, were lower than control values in p34SEI-1¨Cexpressing cells, suggesting that p34SEI-1 inhibits doxorubicin-induced cellular senescence in MCF7, human breast cancer cells. Cells treated with p34SEI-1-siRNA were compared for SA-¦Â-Gal activity with those treated using scrambled RNA. SA-¦Â-Gal activity of p34SEI-1-siRNA¨Ctreated cells that were stained 4 days after doxorubicin treatment was increased as much as control cells that were stained at 6 days, suggesting that p34SEI-1 silencing sensitizes cells to doxorubicin.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 19,903,772 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NPM1
|
4869
|
protein coding
|
MEF
|
--
|
Aging
|
Accelerate
|
BrdU assay//Cell morphological analysis//SA--gal activity assay
|
Fibroblasts that overexpressed NPM remained viable for several days but did not incorporate bromodeoxyuridine.Morphologically the cells became flat, enlarged and positive for acidic ¦Â-galactosidase (SA-¦Â-Gal), a marker of senescence.
|
p53
|
Upregulation
|
Cell counting//Western blot//qRT-PCR
|
The physical association and colocalization of NPM and p53, and its ability to induce cellular senescence in a p53-dependent manner, suggest that NPM might regulate p53 activity directly.GFP¨CNPM inhibited the growth of human WI38 cells and caused a marked upregulation in the amounts of p53, hdm2 and p21 proteins.Increased transcription of hdm2 and p21 was con-firmed at the mRNA level by quantitative polymerase chain reaction.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 12,080,348 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MDM2
|
4193
|
protein coding
|
LS8817
|
--
|
Cancer
|
Prevent
|
SA--gal activity assay//Western blot
|
It is well known that enforced expression of MDM2 does not increase its abundance in cycling cells; however, enforced expression did prevent the PD0332991-induced reduction in MDM2. Accumulation of phospho-Rb and cyclin A were also reduced.However, it prevented the CDK4i-induced accumulation of SA-¦Â-gal positive cells.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,803,170 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ID1
|
3397
|
protein coding
|
PC-3
|
--
|
Prostate cancer
|
Prevent
|
CCK-8 assay//Knockdown//SA--gal activity assay
|
Cell viability was decreased by more than 20% in siRNA-Id1 cells compared with that in nonspecific siRNA control cells, more than 30% of cells in siRNAId1 showed the appearance of enlarged blue cells in contrast to the siRNA control cells (P < 0.01).
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 20,881,502 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NF1
|
4763
|
protein coding
|
--
|
Mice ear
|
Melanoma
|
Accelerate
|
Knockdown//SA--gal activity assay
|
Importantly, we found that deep dermal lesions derived from control Tyr::CreER T2 ; Braf CA/+ mice stained positive for senescence associated¨C¦Â-galactosidase, as has been shown in human nevi and in lesions within the Braf V600E - driven mouse model described by Dhomen and colleagues . However, senescence was not observed in Tyr::CreER T2 ; Braf CA/+; Nf1 flox/flox mice. These results are consistent with our cellular studies and indicate that mutations in Nf1 prevent Braf -induced senescence of melanocytes in mice, thereby rescuing the proliferative restriction and triggering excessive proliferation.
|
--
|
--
|
--
|
--
|
PI3K-Akt-mTOR
|
--
|
Western blot
|
Moreover,Nf1 mutations minimized the suppressive effects of Braf mutations on this pathway.Notably, we found that the PI3K inhibitor GDC-0941 prevented melanocytic hyperplasia in Tyr::CreER T2;Braf CA/+ ; Nf1 flox/flox mice,showing that Nf1 loss was mediating its effects in melanocytes, in part, by permitting or enhancing the activation of this pathway.
|
Human
|
L
|
delay aging
| 23,171,796 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ICMT
|
23463
|
protein coding
|
Fibroblast
|
--
|
Hutchinson-Gilford progeria syndrome
|
Accelerate
|
Growth curve assay//Knockdown
|
As expected,Zmpste24?/? Icmt+/+ fibroblasts proliferated slowly and senesced prematurely. In contrast, Zmpste24?/? Icmthm/hm and Zmpste24?/? Icmt¡÷/¡÷ cells proliferated at rates similar to those of wildtype cells.
|
prelamin A
|
--
|
DAPI
|
prelamin A was mainly found at the nuclear rim in Zmpste24?/?Icmt+/+hepatocytes,colocalizing with LAP2b.In contrast,prelamin A in Zmpste24?/?Icmthm/hm hepatocytes was abundant in the nucleoplasm.
|
Akt-mTOR
|
--
|
Knockdown//Western blot
|
We observed higher levels of phosphorylated AKT and greater mTOR activation in Zmpste24?/? Icmthm/hm cell lysates than in Zmpste24?/? Icmt+/+ lysates, evident by increased phosphorylation of its downstream targets ribosomal protein S6 and 4E-BP1. Similar results were observed in comparisons of Zmpste24+/+Icmthm/hm and Zmpste24+/+ Icmt+/+ cells. Consistent with increased rates of proliferation, Zmpste24?/? Icmthm/hm cells had lower levels of the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1 and the tumor suppressors p16INK4A and phosphorylated retinoblastoma protein (Rb).
|
Human
|
L
|
delay aging
| 23,686,339 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT1
|
23411
|
protein coding
|
HUVEC
|
--
|
Atherosclerosis
|
Prevent
|
Knockdown//SA--gal activity assay
|
We observed that the adenovirus-mediated SIRT1 knockdown directly induced senescence in young HUVECs. Conversely, SIRT1 overexpression significantly decreased SA-¦Â-gal activity in senescent HUVECs, suggesting that SIRT1 protects against endothelial replicative senescence.
|
PAI-1
|
Downregulation
|
Western blot//qRT-PCR//Knockdown
|
PAI-1 expression was dramatically enhanced after SIRT1 knockdown at both the mRNA and protein levels in young HUVECs, while SIRT1 overexpression markedly inhibited PAI-1 expression at both the mRNA and protein levels in senescent HUVECs.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,040,736 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SERPINE1
|
5054
|
protein coding
|
HUVEC
|
--
|
Aging
|
Accelerate
|
SA--gal activity assay
|
CPAI-Q123K, HPAI-RR, and the negative control PAI-L all failed to directly induce HUVEC senescence, whereas CPAI resulted in SA-¦Â-gal-positive staining in nearly 40% of HUVECs. Moreover, treatment of senescent HUVECs with the PAI-1 inhibitor PAI-039 significantly decreased the senescent cell ratio in a dose-dependent manner.we added PAI-039 into young HUVECs infected with Ad-U6 or Ad-SIRT1 RNAi and observed that PAI-1 inhibition significantly reversed the senescence induced by SIRT1 knockdown in HUVECs. The results showed that treatment with an exogenous stable form of PAI-1 CPAI, but not CPAI-Q123K, HPAI-RR, and PAI-L, nearly completely blocked the antisenescence effect of adenovirus-mediated SIRT1 overexpression in senescent HUVECs.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,040,736 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDKN2A
|
1029
|
protein coding
|
C6
|
--
|
Aging
|
Accelerate
|
Cell morphological analysis//Colony formation assay//SA--gal activity assay
|
The control cells surviving G418 selection in the colony formation assays were not altered morphologically, however we noticed the pCLp16 infected cells were flattened, large, or bi-polar. These morphological changes may suggest that the cells had entered senescence. only large or bipolar C6 cells infected with pCLp16 survived selection and, in addition, were stained blue by the SA-¦ÂGal assay.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 11,983,028 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DUSP16
|
80824
|
protein coding
|
PLC-PRF-5
|
--
|
Aging
|
Prevent
|
SA--gal activity assay
|
Intriguingly, the percentage of SA-¦Â-Gal-positive cells significantly increased upon DUSP16 silencing.
|
Rb
|
--
|
Western blot//Knockdown
|
In PLC/PRF/5 cells, we observed that decreased levels of Cyclin-dependent kinases (CDKs) upon DUSP16 silencing led to reduced phosphorylation of Rb,as well as reduced phosphorylation of Rb upon DUSP16 silencing.
|
p53
|
--
|
Western blot//Knockdown
|
Upon DUSP16 knockdown, p53 downstream effectors were dramatically up-regulated . we confirmed that p53 phosphorylation was increased upon DUSP16 knockdown.
|
Human
|
HL
|
delay aging
| 26,381,291 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RAPGEF4
|
11069
|
protein coding
|
ESC
|
--
|
Decidualization of Human Endometrial Stromal Cell
|
Prevent
|
Cell morphological analysis//Knockdown//SA--gal activity assay//Western blot
|
The intensity of SA-¦Â-Gal staining was significantly increased in the EPAC2 siRNA-treated group compared with the control.When the expression of p53 and p21 was examined in these cells, knockdown of EPAC2 suppressed p53 levels and increased p21 levels.Double knock-down of EPAC2 and p21 reduced the ratio of SA-¦Â-Gal-positive cells when compared with single knock-down of EPAC2.
|
CRT
|
--
|
Western blot//Knockdown//qRT-PCR
|
Consistent with the results of LC-MS/MS analysis, EPAC2 knock-down significantly suppressed CRT expression, regardless of the presence of cAMP analogs.real-time RT-PCR analysis showed that EPAC2 knock-down inhibited expression of CRT mRNA in each group, with or without cAMP analogs.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 24,169,561 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CALR
|
811
|
protein coding
|
ESC
|
--
|
Decidualization of Human Endometrial Stromal Cell
|
Prevent
|
Cell morphological analysis//Knockdown//SA--gal activity assay//Western blot
|
The intensity of SA-¦Â-Gal staining was significantly increased in the CRT siRNA-treated group compared with the control.When the expression of p53 and p21 was examined in these cells, knockdown of CRT suppressed p53 levels and increased p21 levels.Double knock-down of CRT and p21 reduced the ratio of SA-¦Â-Gal-positive cells when compared with single knockdown of CRT.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 24,169,561 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CEBPB
|
1051
|
protein coding
|
PB-TRE,PB-CEBPB,LNCaP-shNTV
|
--
|
Prostate cancer
|
Accelerate
|
Flow cytometry//Immunostaining//SA--gal activity assay//qRT-PCR
|
Cells expressing shCEBPB or shNTV both went into G1 cell cycle arrest when cultured in androgen depleted media (ADM).Compared to control PB-TRE, PB-CEBPB cells had a significantly increase in the number SA-¦Â-gal positive cells and the level of cell granularity, as assessed by side scatter.overexpression of C/EBP¦Â led to a significant increase in the transcript levels of two SASP-associated genes, IL8 and IGFBP3. When cultured in ADM, LNCaP-shNTV cells display a 2-fold increase in the number of HF positive cells.the proportion of Ki67-negative cells after one week of culture in ADM was 2-fold lower in cells lacking C/EBP¦Â.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 25,772,238 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
JPT1
|
51155
|
protein coding
|
A549,HUVEC
|
--
|
Cancer
|
Prevent
|
CCK-8 assay//EdU assay//Knockdown//SA--gal activity assay//qRT-PCR
|
All three cell lines showed decreased proliferation rate and increased percentage of senescence-associated SA-¦Â-Gal positive cells.Second, decreased DNA synthesis rate was observed in HN1-KD cells by the EdU incorporation assay.LMNB1, a senescence marker indicating nuclear changes of senescent cells ,showed significantly decreased expression in both HN1-KD HUVECs and A549 cells.The result showed that HN1-KD induced down-regulation of CDK1, CCNB1 and up-regulation of IL6 in both HUVECs and A549 cells.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 31,257,225 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
HNRNPA1
|
3178
|
protein coding
|
HUVEC,A549
|
--
|
Cancer
|
Prevent
|
CCK-8 assay//Flow cytometry//Knockdown//SA--gal activity assay//Western blot//qRT-PCR
|
HNRNPA1-KD led to a higher percentage of positive SA-¦Â-Gal stained cells and slower cell growth rate in both cell types. Besides, HNRNPA1-KD HUVECs and A549 cells also showed arrested G2/M phase, decreased LMNB1 expression, increased ROS production, and altered expression of senescence-associated molecular markers (including CDK1, CDK2, CCNB1, and IL6), resembling to the effects caused by HN1-KD.
|
HN1-L
|
--
|
qRT-PCR//Knockdown
|
Knockdown of HNRNPA1 or HNRNPM could promote the relative expression of HN1-L compared to total expression (HN1-L and HN1-S, labelled as HN1-T), but HNRNPA1 demonstrated the maximun effect, so HNRNPA1 was choosed for further investigation. the increased L/T ratio in HNRNPA1-KD cells could be reversed with HNRNPA1 overexpression.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 31,257,225 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MYC
|
4609
|
protein coding
|
hTERT-immortalized WRN?/? Fibroblast strains AG00780,hTERT-immortalized WRN?/? Fibroblast strains AG03141
|
--
|
Aging
|
Accelerate
|
Knockdown//Microarray//SA--gal activity assay
|
However, within 2¨C3 passages, ¡«30%¨C70% of the WRN¨C/¨C cells expressed senescence-associated (SA-) ¦Â-galactosidase and lost proliferative capacity. The senescent phenotype in c-myc-transduced WRN¨C/¨C cells was also confirmed at the gene expression level by microarray analysis, which demonstrated elevated expression of several genes characteristic of replicative senescence, such as the matrix proteases. In contrast, only a small percentage of the hTERT+ WRN¨C/¨C cells transduced with a control retroviral vector expressed SA-¦Â-gal (¡«1%), similarly to hTERT-immortalized normal fibroblasts (hTERT+, from two independent donors) upon MYC overexpression.
|
WRN
|
Binding
|
CHIP//qRT-PCR//Co-IP
|
Comparable results demonstrating increased WRN A and B site binding by MYC were obtained in four different cell lines expressing deregulated c-myc.In vivo binding of MYC to the WRN promoter and a modest but consistent elevation in histone H4 acetylation, as observed for other MYC-target genes (Frank et al. 2001), was also shown by duplex PCR in the B-cell line P-493-6 that expresses a Tet-Myc-repressible gene.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 12,842,909 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
WRN
|
7486
|
protein coding
|
hTERT+ Fibroblast
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay
|
WRN-depleted cells proliferated poorly compared to empty vector or cells expressing a control RNAi . MYC overexpression failed to rescue theproliferative capacity of WRN-depleted cells and led to a significant increase in the percentage of SA-¦Â-gal-positive cells.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 12,842,909 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CHEK2
|
11200
|
protein coding
|
BJ,Fibroblast,iG4 Terc?/?Fibroblast
|
Colon
|
Telomere dysfunction
|
Accelerate
|
Immunostaining//Knockdown//Western blot
|
Infection of late©\passage, primary human BJ fibroblasts with lentiviral vectors expressing a CHK2©\directed shRNA confirmed that CHK2 knockdown abrogated the induction of senescence, resulting in positive selection of CHK2©\knockdown cells and improved proliferation rates of human fibroblast cultures at late passage. Similar results were obtained for mouse ear fibroblasts. Genetic deletion of CHK2 rescued proliferation of iG4 Terc?/? fibroblasts. Immunofluorescence staining of phosphorylated CHK1 showed nuclear staining of phospho-CHK1 in intestinal basal crypts and progenitor cells of iG4 mice. Immunofluorescence on CHK1-shRNA-treated cells confirmed the staining specificity. In addition, western blot analysis of intestinal epithelium reconfirmed the activation of CHK1 in iG4 and iG4 Chk2?/? mice.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 20,577,265 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TP53
|
7157
|
protein coding
|
HSC
|
--
|
Aging
|
Accelerate
|
Cell counting//DAPI staining//Ki67 staining//RT-PCR//SA--gal activity assay
|
We found a time-dependent increase in TP53 mRNA level expression upon Dox removal. We also found increased expression of CDKN2A (encoding p16INK4A) and CDKN1A (encoding p21), genes important in inducing cell cycle arrest and senescence25, after Dox was withdrawn. HSCs after Dox removal showed increased SA-¦Â-gal (senescence-associated ¦Â-galactosidase) activity with reduced cell proliferation, measured by cell number by 4¡ä,6-diamidino-2-phenylindole (DAPI) and quantifying cells positive for Ki67 staining.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 30,962,418 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FASN
|
2194
|
protein coding
|
HSC
|
--
|
Aging
|
Accelerate
|
Knockdown//RT-PCR//SA--gal activity assay//Western blot
|
FASN knockdown in senescent HSCs prevented the senescent-induced cell cycle arrest, in addition to preventing the upregulation of different markers of senescence such as SA-¦Â-gal activity, p53, p16 and p21. Notably, FASN knockdown also inhibit the increase in the expression of mRNA levels of SASP factors IL1A, IL1B and IL6 in HSCs.
|
--
|
--
|
--
|
--
|
mTOR
|
--
|
Western blot
|
To our surprise,mTOR activity was repressed during senescence as shown by a decrease in the phosphorylation levels of some of its downstream targets: S6, 4EBP1 and AKT. Remarkably, senescent cells treated with C75 were able to restore mTOR signalling at levels similar to control.
|
Human
|
L
|
delay aging
| 30,962,418 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TRPM7
|
54822
|
protein coding
|
BxPC-3,PANC-1
|
--
|
Pancreatic cancer
|
Prevent
|
Cell morphological analysis//Knockdown//SA--gal activity assay//qRT-PCR
|
Consistent with the observations in the micrographs with phase contrast, bright field examination reveals that both BxPC-3 and PANC-1 cells with targeted knock down of TRPM7 expression exhibit morphological features indicative of a senescent phenotype. In the BxPC-3 and PANC-1 cells transfected with anti-TRPM7 siRNA but not in the controls, SA ¦Â-gal activity was detected.In TRPM7-deficient PANC-1 cells, the mRNA levels of p16INK4A and WRN were elevated whereas that of p27CDKN1B remained unaltered. Similarly, in TRPM7-deficient BxPC-3 cells, the mRNA levels of p16INK4A and WRN were elevated by 1.4-fold and 26%, respectively.
|
WRN
|
--
|
qRT-PCR
|
In TRPM7-deficient PANC-1 cells, the mRNA levels of p16INK4A and WRN were elevated whereas that of p27CDKN1B remained unaltered. Similarly, in TRPM7-deficient BxPC-3 cells, the mRNA levels of p16INK4A and WRN were elevated by 1.4-fold and 26%, respectively.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 22,166,235 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
HMGB2
|
3148
|
protein coding
|
IMR-90
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay//Western blot//qRT-PCR
|
We validated that HMGB2 expression was decreased at both the mRNA and protein levels during senescence of normal primary human embryonic fibroblast IMR90 cells induced by oncogenic RAS.knockdown or knockout of HMGB2 induced senescence in IMR90 cells .
|
C/EBP-¦Â//SASP
|
Binding//--
|
Knockdown//CHIP-seq//CHIP//qRT-PCR
|
C/EBP-¦Â is a direct target gene of HMGB2 in senescent cells, and knockdown of HMGB2 decreased C/EBP-¦Â gene expression.Loss of HMGB2 allows for spreading of heterochromatin marks and promotes the inclusion of SASP gene loci into SAHF, which in turn represses SASP gene expression.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 27,799,366 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
SMARCD1
|
6602
|
protein coding
|
TIG-1,Hepatocyte,Hepatocyte
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay//Western blot
|
Results show that the relative number of cells with increased senescence-associated ¦Âgalactosidase (SA-¦Â-Gal) activity, p16/p21 expression, and phospho p38 (p-p38) expression is increased in SMARCD1-silenced TIG1 cells.In contrast, cellular senescence was shown to be suppressed in senescent TIG-1 cells (61 PDL) where SMARCD1 was ectopically expressed, as evidenced by a decreased number of senescence marker-positive cells in SMARCD1-overexpressing TIG-1 cells. Furthermore, SMARCD1 expression attenuated the replicative senescence-induced growth retardation.we evaluated the effect of Smarcd1-knockdown on the cellular senescence induction in mouse primary hepatocytes, indicating that Smarcd1 knockdown also induced cellular senescence in normal hepatocytes.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 28,868,154 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HSP90AA1
|
3320
|
protein coding
|
IMR-90,HFF
|
--
|
Lung cancer
|
Prevent
|
Knockdown//SA--gal activity assay
|
Regardless of the concentration, GA treatment doubled or tripled the amount of ¦Â-galactosidase-positive senescent IMR90 fibroblasts and HFFs compared to controls .As expected, HSP90¦Á or ¦Â knockdown by isoform-specific HSP90 siRNAs accelerated cellular senescence.
|
p14
|
--
|
Western blot
|
GA treatment or HSP90 ablation induced an increase in p14ARF protein levels and prolonged the half-life of the p14ARF protein under cycloheximide (CHX) treatment in the human cervical cancer cell line HeLa.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 27,793,846 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HSP90B1
|
7184
|
protein coding
|
IMR-90,HFF
|
--
|
Lung cancer
|
Prevent
|
Knockdown//SA--gal activity assay
|
Regardless of the concentration, GA treatment doubled or tripled the amount of ¦Â-galactosidase-positive senescent IMR90 fibroblasts and HFFs compared to controls.As expected, HSP90¦Á or ¦Â knockdown by isoform-specific HSP90 siRNAs accelerated cellular senescence.
|
p14
|
--
|
Western blot
|
GA treatment or HSP90 ablation induced an increase in p14ARF protein levels and prolonged the half-life of the p14ARF protein under cycloheximide (CHX) treatment in the human cervical cancer cell line HeLa.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 27,793,846 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT6
|
51548
|
protein coding
|
HUVEC
|
--
|
Aging
|
Prevent
|
BrdU assay//Immunostaining//SA--gal activity assay
|
SIRT6-silenced cultures showed decreased rates of proliferation and a reduction in the cell fraction passing through the S-phase.SIRT6-silenced cultures also displayed an increase in the proportion of SA-¦Â-gal+ cells.In SIRT6-depleted HUVEC, there was a significant increase in ¦ÃH2AX foci.
|
--
|
--
|
--
|
--
|
p21
|
--
|
Western blot
|
This analysis showed higher levels of p21 expression in SIRT6-depleted cells compared with controls.
|
Human
|
L
|
delay aging
| 23,201,774 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIF
|
4282
|
protein coding
|
MSC
|
--
|
Myocardial infarction
|
Prevent
|
Knockdown//SA--gal activity assay//Western blot
|
MIF-siRNA treatment of young MSCs significantly downregulated MIF expression, while it significantly elevated p53 and p21 expression. Furthermore, MIF-siRNA treatment remarkably increased the number of SA-¦Â-gal-positive cells among young MSCs.While the overexpression of MIF in aged MSCs enhanced MIF expression, it reduced p53 and p21 expression. Moreover, the percentage of SA-¦Â-gal-positive cells was greatly reduced in MIF-aged MSCs compared with aged MSCs.
|
Beclin1//LC3-I/II//p62
|
Upregulation//Upregulation//Downregulation
|
Western blot
|
Autophagy has recently been found to inhibit cellular senescence.Overexpression of MIF in aged MSCs significantly induced autophagy, as manifested by the elevated expression of Beclin1 and LC3I/II and the reduced expression of p62.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 31,881,006 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ZBTB48
|
3104
|
protein coding
|
pMSC
|
--
|
Aging
|
Accelerate
|
SA--gal activity assay//Western blot//qRT-PCR
|
Overexpression of TZAP in P2 pMSCs resulted in an increase in the percentage of SA-¦Â-gal-positive cells by 17% (from 6 to 23%). Western blot analysis showed that compared to the control vector, TZAP over-expression in pMSCs significantly increased the protein levels of P21 and P16. Consistent with this finding, qRT-PCR also revealed upregulated transcript levels of p21 and p16Ink4a.
|
--
|
--
|
--
|
--
|
p53
|
Upregulation
|
Western blot
|
After overexpression of TZAP in pMSCs, western blot analysis showed that overexpression of TZAP led to increased levels of ARF, P53 and P21 but decreased levels of MDM2 compared to those in pMSCs transduced with the control vector. In contrast, knockout of TZAP in pMSCs decreased ARF, P53, and P21 levels but increased MDM2 levels .
|
Human
|
HL
|
delay aging
| 30,845,965 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
NFATC1
|
4772
|
protein coding
|
prostate epithelial cell
|
--
|
Prostate cancer
|
Prevent
|
Immunostaining//Knockdown//SA--gal activity assay
|
There was a marked decrease in the expression of the senescence marker p21 in PCre/+;RT/+;TN/+;Ptenfl/fl samples when compared with the PCre/+;Ptenfl/fl mice. p21 staining was predominantly nuclear in PCre/+;Ptenfl/fl prostates (63.6 ¡À 7.95%). In contrast, nuclear p21 expression was absent in PCre/+;RT/+;TN/+;Ptenfl/fl (4.2 ¡À 1.30%) prostates, where cytoplasmic p21 was occasionally observed.To further confirm that NFATc1 activation overcomes PTEN lossinduced cellular senescence, we stained for senescence-associated ¦Â-galactosidase (SA-¦Â-gal) activity in the prostates. Control and PCre/+;RT/+;TN/+ prostates showed very few senescent cells, 1% and 6.66 ¡À 0.5%, respectively. In contrast, 65.6 ¡À 8.7% cells within the PCre/+;Ptenfl/fl prostates were SA-¦Â-gal+. Such SA-¦Â-gal+ cells in the PCre/+;RT/+;TN/+;Ptenfl/fl prostates were markedly reduced to 5.8 ¡À 1.3%.
|
--
|
--
|
--
|
--
|
PTEN-AKT
|
Activation
|
Immunostaining
|
Interestingly, all double mutants (PCre/+;RT/+;TN/+;Ptenfl/fl) with both PTEN deficiency and NFATc1 activation developed significantly larger tumors in all prostate lobes when compared with mice of the same age with either Pten deficiency or NFATc1 activation alone . The average prostate weight in double mutants (6026.24¡À1946.85?mg) was increased 17.41-fold when compared with the controls (346.85¡À36.66?mg), 15.45-fold when compared with mice with NFAT activation alone (390.28¡À73.16?mg), 7.35-fold when compared with Pten null mice. Histopathological analyses revealed that Pten null mice and mice with NFATc1 activation alone had PIN at this time, whereas double mutants already had poorly differentiated prostatic adenocarcinoma. Although levels of pAKT were low in prostates from controls and mice with only NFATc1 activation, increased expression of pAKT was apparent in PCre/+;Ptenfl/fl and PCre/+;RT/+;TN/+;Ptenfl/fl samples, indicating that the PI3K-AKT pathway was activated in prostates with PTEN loss.
|
Human
|
HL
|
delay aging
| 26,477,312 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MAD2L1
|
4085
|
protein coding
|
MKN45
|
--
|
Gastric cancer
|
Prevent
|
SA--gal activity assay//qRT-PCR
|
With this experiment, we determined that the fraction of SA-¦Â-gal-positive cells increases 3d after Mad2 depletion. When we analyzed its activation after 72 h of PTX treatment, we observed an increase in p53 mRNA levels in cells lacking Mad2.IL-6 (and not IL-8) expression was attenuated when Mad2 was decreased.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,483,095 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
BUB1B
|
701
|
protein coding
|
MKN45
|
--
|
Gastric cancer
|
Prevent
|
SA--gal activity assay//qPCR
|
With this experiment, we determined that the fraction of SA-¦Â-gal-positive cells increases 3d after BubR1 depletion. When we analyzed its activation after 72 h of PTX treatment, we observed an increase in p53 mRNA levels in cells lacking BubR1. Both IL-6 and IL-8 mRNA levels were increased during senescence in the absence of BUB1B.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,483,095 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
NUPR1
|
26471
|
protein coding
|
A549,H460
|
--
|
Lung cancer
|
Prevent
|
BrdU assay//Colony formation assay//Flow cytometry//Knockdown//SA--gal activity assay//Western blot
|
In this regard, NUPR1 depletion in A549 or H460 cells caused a marked increase in the number of GLB1 (galactosidase beta 1)-positive cells. Consistent with the induction of GLB1, NUPR1 depletion induced G0/G1 cell cycle arrest, with significant upregulation of the key cell cycle inhibitors CDKN1A/p21Cip1 and CDKN1B/ p27Kip1, but not CDKN2A/p16INK4a. NUPR1 knockdown also inhibited cell growth, as evidenced by BrdU incorporation and colony formation assays.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 29,130,426 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HRAS
|
3265
|
protein coding
|
IMR-90
|
--
|
Cancer
|
Accelerate
|
SA--gal activity assay//Western blot
|
Cells infected with the retrovirus expressing HRASG12V fail to proliferate and stained positive for senescence-associated ¦Â-galactosidase (SA-¦Âgal) activity.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 24,618,719 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CUX1
|
1523
|
protein coding
|
IMR-90
|
--
|
Cancer
|
Prevent
|
SA--gal activity assay//Western blot
|
Co-expression of p200 CUX1 enabled RAS expressing cells to proliferate normally and prevented SA-¦Âgal activity.
|
OGG1
|
Activation
|
Western blot
|
The enzymatic activity of OGG1 was greatly stimulated by recombinant CUX1 proteins containing one or more Cut repeat domain(s): CR2CR3HD, CR3HD, and CR1CR2.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 24,618,719 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ASXL1
|
171023
|
protein coding
|
MEF
|
--
|
Aging
|
Prevent
|
Cell morphological analysis//DAPI staining//Microarray//SA--gal activity assay//SAHF//Western blot//qRT-PCR
|
SA-¦Â-gal staining was significantly greater in two different passages of Asxl1-null MEFs than in WT MEFs. Consistently, more SAHF were formed in Asxl1-null MEFs as determined by DAPI staining.More senescence was induced at passage 6 of Asxl1-null MEFs because of growth retardation in the later stages. In addition, Asxl1-deleted MEFs displayed an enlarged and flattened shape (data not shown).Notably,the up-regulation of another Cdk inhibitor, p16Ink4a (a hallmark of cellular senescence),was observed in Asxl1-null cells, whereas p21Waf1 was down-regulated at the protein and RNA levels.In addition to p16Ink4a, other senescence -associated genes such as p57Kip2, Mmp1, and Pai1 were also up-regulated as shown by microarray analysis and RT-qPCR.
|
E2F//EZH2
|
--//--
|
qRT-PCR//Co-IP
|
Most of the E2F target genes were significantly down-regulated in Asxl1-null.To explore the link between ASXL1 and EZH2,we first measured the physical interaction by co-IP analysis. As reported previously, Flag-EZH2 interacts with endogenous ASXL1.
|
Akt-E2F
|
--
|
Western blot//CHIP
|
A significant decrease in p27Kip1 phosphorylation was observed in Asxl1-null MEFs, which was likely due to Akt inactivation. As shown by IP assays using HEK293 cells treated with IGF-1, we demonstrated that p27Kip1 interacts with both ASXL1 and AKT1 regardless of IGF-1¨Cinduced AKT phosphorylation. Consistent with reports shown above, IGF-1 treatment induced the cytoplasmic export of p27Kip1 in normal MEFs, whereas the IGF-1 effect was abolished in Asxl1-null MEFs; p27Kip1 was thus retained in the nucleus. Consequently, we observed a gradual down-regulation of Rb phosphorylation, but no change in the Rb level, during culture of Asxl1-null MEFs. In response to IGF-1, no effect of Asxl1 was observed on E2F1 binding to the Ccna2 promoter, while the IGF-1¨Crepressed Rb binding was recovered in Asxl1-null MEFs after Rb activation.
|
Human
|
HL
|
delay aging
| 28,701,722 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
RELA
|
5970
|
protein coding
|
Human low-grade PanIN cell
|
Pancreata
|
Pancreatic ductal adenocarcinoma
|
Accelerate
|
SA--gal activity assay//Western blot//qPT-PCR
|
Quantification of SA-¦Â-Gal¨Cpositive cells in low-grade mPanIN lesions from Kras and Kras RelA mice demonstrated loss of SA-¦Â-Gal activity in Kras RelA mPanIN.In addition, the senescence marker decoy receptor 2 (DCR2; also known as TNFRSF10D) was significantly lower in Kras RelA pancreata than in Kras pancreata on both an mRNA expression and a protein level.GSEA demonstrated a loss of the SASP signature in Kras RelA mice.
|
CXCL1
|
--
|
Western blot//SA-¦Â-gal activity assay
|
Of the 40 cytokines and chemokines represented in this panel, CXCL1 (also known as KC) was most robustly downregulated in PDEC Kras treated with JSH-23. The decrease in CXCL1 protein levels was corroborated by an increased SA-¦Â-Gal activity in PDEC Kras incubated with CXCL1 for 48 hours .In Kras pancreata, Cxcl1 mRNA expression was moderately to strongly present in the cytoplasm of most duct cells in mPanIN lesions, in acinar cells around mPanIN lesions, and in immune cells.Cxcl1 mRNA was present in immune cells, only faintly present in a few duct cells, and absent in the majority of acinar cells in Kras RelA pancreata.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 27,454,298 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
NTN4
|
59277
|
protein coding
|
U251MG,pcDNA3
|
--
|
Glioblastoma
|
Prevent
|
SA--gal activity assay
|
We observed significantly fewer senescent NTN4-overexpressing cells compared with mock control cells.Thus, NTN4 overexpression delayed U251MG cell senescence induced by H2O2.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 30,514,230 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EGF
|
1950
|
protein coding
|
U251MG
|
--
|
Glioblastoma
|
Prevent
|
SA--gal activity assay
|
On the 4th day after H2O2 treatment, we observed less senescence in U251MG cells treated with EGF compared with non-EGF treated cells. On the 7th day after H2O2 treatment, the number of senescent cells in the EGF treatment group was significantly less than that in the non-treatment control group.There was a significant difference in U251MG senescence between cells treated and not treated with EGF for 7?days. With EGF (40?ng/ml) treatment, senescence of U251MG cells induced by H2O2 decreased. The concentration of 40?ng/ml EGF inhibited U251MG cell senescence efficiently.
|
NTN4
|
Upregulation
|
qRT-PCR//Immunostaining
|
We observed that NTN4 expression were significantly increased upon EGF stimulation at both mRNA level and protein level.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 30,514,230 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COPS5
|
10987
|
protein coding
|
MEF
|
--
|
Cancer
|
Prevent
|
Cell morphological analysis//SA--gal activity assay//Western blot
|
Under the microscope, 4OHT©\treated cells appeared flatter, a typical feature of senescent cells. We, therefore, assayed for senescence©\associated (SA) ¦Â©\galactosidase (Gal) activity, another marker of premature senescence.Lower panels show that 4OHT©\treated CSN5f/©\p53?/?Ras+CRE©\ER MEFs were positive for SA©\¦Â©\Gal activity.As cells underwent senescence, the expression of the CDK inhibitors p21, p27, and p16 was upregulated and hypo©\phosphorylated Rb protein was accumulated, whereas the level of Skp2 was maintained.
|
--
|
--
|
--
|
--
|
PI3K-Akt
|
--
|
Western blot//Knockdown
|
Although the total expression levels of ERK1, ERK2, and Akt were maintained, their activating phosphorylation was modulated by knockout of the CSN5 gene. The Activate form of ERK1 and 2 was reduced, whereas the activating phosphorylation of Akt (serine 473 and threonine 308) was increased after treatment with 4OHT. Furthermore, the phosphorylation of certain substrates of Akt was enhanced in cells deprived of CSN5.We observed the same phenotype when we used a chemical inhibitor more specific to PI3 kinase, LY294002.
|
Human
|
L
|
delay aging
| 23,127,558 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CNOT6
|
57472
|
protein coding
|
MCF-7
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay
|
Consistent with the role of IGFBP5, knockdown of Ccr4a/Ccr4b caused a significant increase in senescence-associated ¦Â-galactosidase staining as compared with control or Caf1a/Caf1b knockdown.
|
IGFBP5
|
--
|
Knockdown//qRT-PCR
|
We confirmed enhanced expression of IGFBP5 (approximately threefold), CLEC3A (approximately threefold), SEMA3E (approximately twofold), MAPK10 (approximately twofold), CDH18 (approximately twofold), and LMO3 (approximately eightfold) upon Ccr4a/Ccr4b knockdown.
|
p53
|
--
|
Western blot//Knockdown
|
Interestingly, while the overall levels of both total p53 as well as p53 acetylated at Lys-120 were significantly increased in Ccr4a/Ccr4b knockdown cells, the fraction of p53 acetylated at Lys-120 was not increased.
|
Human
|
HL
|
delay aging
| 21,233,283 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CNOT6L
|
246175
|
protein coding
|
MCF-7
|
--
|
Aging
|
Prevent
|
Knockdown//SA--gal activity assay
|
Consistent with the role of IGFBP5, knockdown of Ccr4a/Ccr4b caused a significant increase in senescence-associated ¦Â-galactosidase staining as compared with control or Caf1a/Caf1b knockdown.
|
IGFBP5
|
--
|
Knockdown//qRT-PCR
|
We confirmed enhanced expression of IGFBP5 (approximately threefold), CLEC3A (approximately threefold), SEMA3E (approximately twofold), MAPK10 (approximately twofold), CDH18 (approximately twofold), and LMO3 (approximately eightfold) upon Ccr4a/Ccr4b knockdown.
|
p53
|
--
|
Western blot//Knockdown
|
Interestingly, while the overall levels of both total p53 as well as p53 acetylated at Lys-120 were significantly increased in Ccr4a/Ccr4b knockdown cells, the fraction of p53 acetylated at Lys-120 was not increased.
|
Human
|
HL
|
delay aging
| 21,233,283 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RBM38
|
55544
|
protein coding
|
MEF
|
--
|
Lymphoma
|
Prevent
|
Knockdown//SA--gal activity assay
|
We showed that the number of cells stained positive with senescence-associated ¦Â-galactosidase (SA-¦Â-gal) was markedly increased by lack of RNPC1 regardless of DNA damage . Quantitative analysis indicated that SA-¦Â-gal-positive cells were increased by threefold to eightfold upon loss of RNPC1 (47.5% in RNPC1?/? MEFs vs. 5.5% in RNPC1+/+ MEFs and 6.5% in RNPC1+/? MEFs in the absence of doxorubicin; 64.5% in RNPC1?/? MEFs vs. 18% in RNPC1+/+ MEFs and 19.5% in RNPC1+/? MEFs in the presence of doxorubicin).
|
--
|
--
|
--
|
--
|
p53
|
Downregulation
|
Western blot
|
We showed that p53 was highly induced by RNPC1 deficiency, especially upon treatment with doxorubicin, consistent with the observation. Similarly, transient expression of RNPC1a, but not RNPC1b, inhibited p53 expression in a dose-dependent manner. Furthermore, we showed that upon treatment with doxorubicin or nutlin-3, ectopic expression of RNPC1a markedly attenuated p53 accumulation in MCF7 and RKO cells .
|
Human
|
L
|
delay aging
| 21,764,855 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PYGL
|
5836
|
protein coding
|
U87
|
--
|
Cancer
|
Prevent
|
Cell morphological analysis//Flow cytometry//Immunostaining//Knockdown//SA--gal activity assay
|
Analysis of the cell-cycle profile after PYGL knockdown in U87 cells revealed a higher proportion of cells in G1 phase with concomitant decreases in both S phase and G2/M phase, as compared to control cells.Following PYGL depletion, U87 cells underwent characteristic morphological changes (i.e., enlargement and flattening) that were indicative of cellular senescence.Following PYGL knockdown, we observed an increase in both DEC1 and SA ¦Â-gal staining.
|
--
|
--
|
--
|
--
|
p53
|
--
|
Knockdown//Western blot//Cell counting
|
Knockdown of p53 prevented the decreased growth rate phenotype normally associated with PYGL depletion.
|
Human
|
L
|
delay aging
| 23,177,934 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ENO1
|
2023
|
protein coding
|
CFPAC-1
|
--
|
Pancreatic cancer
|
Prevent
|
Cell morphological analysis//Flow cytometry//SA--gal activity assay//Western blot
|
The cell-cycle profile analysis after 24 h serum deprivation revealed a significant increase in the number of ENO1-silenced cells in G2/M phase, a concomitant decrease of cells in G1 phase and no difference in the number of cells in S phase .there was a decrease in expression of the negative regulator of the cyclin D/CDK complex p18 (INK4C) after ENO1 silencing. ENO1-silenced cells showed characteristic morphological changes, such as enlargement and flattening, which were indicative of cellular senescence, confirmed by ¦Â-galactosidase staining .
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 26,734,996 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NCOA4
|
8031
|
protein coding
|
MEF
|
--
|
Aging
|
Prevent
|
Immunostaining//Knockdown//SA--gal activity assay//Western blot
|
NCOA4?/? cells showed increased activation of the apical DDR kinases ATM and ATR, accumulation of nuclear foci stained for pS/TQ ATM/ATR substrates, and increased phosphorylation of p53 on S15. Furthermore, NCOA4?/? cells displayed an increased number of ¦Ã-H2AX- and 53BP1-positive cells compared to NCOA4+/+ MEFs.Consistently, NCOA4?/? MEFs displayed reduced PDL (population doubling level) accumulation compared to both NCOA4+/+ and NCOA4+/? cells, rapidly exhausted replicative potential, and after four passages, entered premature senescence, as shown by increased ¦Â-galactosidase staining (p < 0.001).
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 24,910,095 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
KLF6
|
1316
|
protein coding
|
LN-229,BTSC233
|
--
|
Glioblastoma
|
Accelerate
|
Flow cytometry//SA--gal activity assay
|
Prolonged expression of KLF6-wt, but not KLF6-sv1, induced a senescent-like phenotype in both LN229 and BTSC23 cells, highlighted by ¦Â-galactosidase staining. Cell cycle analysis revealed accumulation of cells in phase G1¨CG0 and concomitant reduction of cells in phases S and G2/M, upon KLF6-wt expression.In contrast, KLF6-sv1 overexpression prolonged S-phase. In BTSC23 cells, KLF6-wt overexpression led to accumulation of cells in G2/M .Consistent with the G1 arrest observed in LN229 cells, KLF6-wt overexpression led to upregulation of CDKN1A expression in LN229 and BTSC23 cells .
|
--
|
--
|
--
|
--
|
NF-¦ÊB
|
Downregulation
|
Western blot
|
Downregulation of NF-¦ÊB targets MMP9, OLIG2 and YKL40 was confirmed by western blot.
|
Human
|
HL
|
delay aging
| 28,166,199 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ABI3BP
|
25890
|
protein coding
|
GBC
|
--
|
Gallbladder cancer
|
Accelerate
|
EdU assay//SA--gal activity assay//Transwell assay//Western blot
|
The results demonstrated that compared with cells manipulated with vector-NC, cells manipulated with ABI3BP-vector displayed markedly enhanced ability of cell viability, weakened abilities of migration and invasion and promoted SA-¦Â-gal activity, as well as significantly down-regulated expression of Ki67 and PCNA.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 31,174,563 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ATM
|
472
|
protein coding
|
DLD1,HCT116
|
--
|
Colorectal cancer
|
Prevent
|
Flow cytometry//Knockdown//SA--gal activity assay
|
Intriguingly, cell cycle analysis showed that ATM deletion induced a significant G2/M arrest of DLD1 and HCT116 cells under normal conditions.Moreover, we observed a significantly higher number of senescent ATM-/- cells compared with senescent ATM+/+ cells, as determined by SA-¦Â-gal staining .
|
B56¦Ã2
|
Binding
|
Western blot//Co-IP
|
Indeed,western blot analysis showed that B56¦Ã2 expression was significantly increased in ATM-/-cancer cells.Intriguingly, the coimmunoprecipitation experiments showed that ATM and B56¦Ã2 co-immunoprecipitated reciprocally.
|
Chk1-p53-p21
|
--
|
Western blot//Knockdown
|
The results showed that in ATM-/- cells, Cdc2 phosphorylation on Tyr15, which is indicative of decreased Cdc2 activity, was significantly increased . In addition, the phosphorylation of the upstream regulator Chk1 was significantly increased in ATM-/- cells, whereas the phosphorylation of Chk2 was not altered . In accordance with this phenomenon, the phosphorylation levels of p53 and p21, two key regulators of senescence [23], were significantly increased in ATM-/-cells, indicating that ATM deficiency promotes p53/p21-induced senescence.
|
Human
|
HL
|
delay aging
| 28,093,285 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ASAH1
|
427
|
protein coding
|
A375
|
--
|
Melanoma
|
Prevent
|
Cell morphological analysis//Flow cytometry//PI staining//SA--gal activity assay
|
Only 2% of ASAH1-null cells entered the G2 phase, compared to 25% scramble-treated control cells. The remaining ASAH1-null cells were found in G1 (63%) or S (35%) phase. Similarly, ASAH1 deletion was accompanied by the appearance of a phenotype characterized by senescence-like cell morphology and accumulation of senescence-associated ¦Â-galactosidase.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 28,785,021 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RHEB
|
6009
|
protein coding
|
Articular Chondrocyte
|
Bone
|
Osteoarthritis
|
Prevent
|
DAPI staining//SA--gal activity assay
|
RHEB- 9 overexpression not only recovered the morphology of the DCs, but also reduced senescence by 10 35¨C40 %. RHEB-overexpression also decreased ROS levels.
|
COL2A1//SOX9
|
Upregulation//Upregulation
|
Western blot
|
Importantly, 11 RHEB -overexpression increased the level of COL2A1, which was almost negligible in non-transfected DCs. SOX9 expression also increased with RHEB -overexpressing DCs.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 31,229,684 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AGER
|
177
|
protein coding
|
--
|
Lung
|
Aging
|
Prevent
|
Histological staining//Immunofluorescence//Knockdown//SA--gal activity assay
|
The absence of RAGE was associated with an accumulation of fibrotic tissue (as evidenced by Masson's trichrome staining) and senescent lesions, as evidenced by ¦Â-Gal-staining . The accumulation of these senescent lesions was also observed in other tissues of RAGE?/? mice.When markers of senescence associated cellular properties were studied, an increase of IL-6 by ¡«50% and an almost 3-fold increase of ¦ÃH2AX and 53BP1 was seen, while pATM increased by ¡«50%. This is consistent with DNA damage associated senescence and a senescence associated pro-inflammatory phenotype in cells and lungs of RAGE?/? mice , indicating an on-going persistent DNA damage signaling.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 28,977,635 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT1
|
23411
|
protein coding
|
ECFC
|
--
|
Preterm
|
Prevent
|
BrdU assay//Cell morphological analysis//SA--gal activity assay//Western blot
|
Twenty-four hours after transient transfection, SIRT1 overexpression was associated with a significant decrease in the level of the senescence-associated p16INK4a protein;Consistently,transfection of PT-ECFCs with the SIRT1 vector significantly reduced SA-¦Â-gal activity and senescence associated morphological changes, compared with PT-ECFCs transfected with an empty vector;SIRT1 overexpression accelerated PT-ECFC proliferation.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 24,518,759 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FGF21
|
26291
|
protein coding
|
BVSMC
|
--
|
Cerebrovascular aging
|
Prevent
|
SA--gal activity assay//Western blot
|
Treatment of recombinant FGF21 (100 nM) significantly attenuated the positive area of SA-¦Â-gal staining;FGF21 treatment decreased the NBS1.
|
p21//TRF2
|
Downregulation//Upregulation
|
Western blot
|
FGF21 also inhibited the induced p21 expression by AngII.Siah-1 is an E3 ubiquitin ligase degrading TRF2£¬These results suggest that FGF21 enhances TRF2 expression via inhibiting Siah-1 signaling in hBVSMCs.Interestingly, FGF21 partly but significantly inhibited the upregulation of ROS and superoxide anion induced by Ang II .
|
p53//Siah-1//AMPK
|
Downregulation//Downregulation//Activation
|
Western blot//SA-¦Â-gal activity assay
|
FGF21 supplement substantially depressed the both the total p53 and phospho-p53 levels induced by AngII £»FGF21 inhibited Siah-1 expression induced by AngII.FGF21 markedly increased phosphorylation of AMPK in hBVSMCs.SA-¦Â-gal staining assay showed that blockade of AMPK activation by specific inhibitor of AMPK Compound C almost totally abolished the anti-aging action of FGF21.
|
Human
|
L
|
delay aging
| 27,364,911 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT1
|
23411
|
protein coding
|
Clara
|
Lung
|
Chronic obstructive pulmonary disease
|
Prevent
|
SA--gal activity assay//Western blot
|
We found that the level of SIRT1 was decreased, whereas senescence-associated ¦Â-gal activ-ity and p21 expression were increased in lungs of COPD patients compared with nonsmokers.CS exposure significantly increased the levels of prosenescent proteins (i.e., p21, p16, and p53) and SA¨C¦Â-gal activity in lungs of Sirt1+/¨C mice versus WT littermates, whereas these levels were lowered by Sirt1 overexpression.
|
FOXO3//p21
|
--//--
|
SA-¦Â-gal activity assay//Western blot
|
Foxo3¨C/¨C mice exhibited heightened levels of p21, p16, p27, and SA¨C¦Â-gal activity in lungs in response to CS exposure.However, there was no significant change in SA¨C¦Â-gal activity in lungs of p21¨C/¨C mice in response to CS exposure, or along with sirtinol treatment.Moreover, FOXO3 acetylation was increased in Sirt1+/¨C mice,but lowered in Sirt1 Tg mice exposed to CS for 6 months.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 22,546,858 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IHH
|
3549
|
protein coding
|
B-MSC
|
--
|
Aging
|
Prevent
|
Cell morphological analysis//Colony formation assay//Flow cytometry//PI staining//RT-PCR//SA--gal activity assay//Western blot
|
Surprisingly, the count of BMSC cells stained by SA-¦Â-gal stain increased in cells treated with IHH siRNA.Consistently, aging-related genes, p16, p53, SA-¦Â-gal, and mTOR were downregulated after treatment with rIHH.The IHH siRNA transfected BMSC showed more transparency, slight enlargement,and decreased in cell count compared to the negative control.IHH siRNA-transfected BMSC failed to form colonies contrary to the negative control.G0/G1 cell cycle arrest was associated with BMSC of IHH siRNA.
|
--
|
--
|
--
|
--
|
ROS-mTOR-4EBP1
|
Downregulation//--
|
Western blot//Flow cytometry//Colony formation assay//Knockdown
|
We observed down-regulation of P53 and P16 associated with inhibition of mTORand ROS pathways.The cell cycle results showed that inhibition of mTOR and ROS pathways restricted the G0/G1 cell cycle arrest caused by IHH silencing .The colony forming ability of BMSC caused by IHH knockdown was improved after inhibition of mTOR and ROS in the presence of siRNA IHH;As we expected, knockdown of IHH induced 4EBP1 and p70S6K1/2 phosphorylation but rIHH protein treatment down-regulate the phosphorylation process.Our findings presented anti-aging activity for IHH in BMSC through down-regulation of ROS/mTOR pathways.
|
Human
|
L
|
delay aging
| 32,235,006 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NAMPT
|
10135
|
protein coding
|
Adipose stromal cell
|
Adipose
|
Aging
|
Prevent
|
Lifespan assay
|
We started injecting EVs purified from young-to-middle age (4¨C12-month-old) mice once a week into female mice at 26 months of age. supplementation with EVs purified from young-to-middle-aged mice significantly extended the lifespan of aged mice.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 31,204,283 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CALCA
|
796
|
protein coding
|
EPC
|
Blood
|
Aging
|
Prevent
|
SA--gal activity assay//Telomerase activity assay
|
CGRPI lentivirus transduction significantly reduced SA-¦Â-gal positive senescent cells and elevated the activity of telomerase in AngII-treated EPCs.
|
Klotho
|
Upregulation
|
Western blot//qRT-PCR
|
Interestingly, the levels of both Klotho mRNA and secreted Klotho protein were remarkably increased by CGRPI over-expression.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 20,832,068 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ATG7
|
10533
|
protein coding
|
keratinocyte
|
Skin
|
Aging
|
Prevent
|
Microarray
|
PQ treatment induced a transcriptional signature of strong cell cycle arrest and DNA damage signaling in the Atg7 deficient cells.
|
p53//p21//CDK1//H2AX
|
--//--//--//--
|
Western blot//qRT-PCR//Immunostaining
|
p53 and the downstream mediator p21 were induced by PQ on mRNA and protein level, and the induction was increased in the knockouts on protein level for both proteins.Using qPCR we could verify that the knockout cells showed higher baseline expression of Cdk1.Using WB we could show that this was reflected on protein level, with a stronger Cdk1 signal in untreated KO. We exposed the cells to UVA, which did not cause a significant rise in positive nuclei in WT cells, but did so in KO cells.
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 28,012,437 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FOXQ1
|
94234
|
protein coding
|
HUCMSC
|
Umbilical cord
|
Alzheimer's disease
|
Prevent
|
CCK-8 assay//Cell morphological analysis//PI staining//SA--gal activity assay//Western blot//qRT-PCR
|
Cell viability was significantly enhanced in the P15-FOXQ1 group compared with that in the P15-vector group on day 4.Meanwhile, the morphology of cells in the P15-FOXQ1 group was changed slightly compared with those in the P3 group,with the spindle shape maintained in most cells. The number of SA-¦Â-gal-positive cells was noticeably reduced in the P15-FOXQ1 group.Compared with the P15-vector group,expression of positive senescence-associated genes such as p16,p21 and p53 was down-regulated at the mRNA level. At the mRNA and protein level,Expression of negative senescence-associated genes, such as SIRT1 and PCNA, was up-regulated.A significantly higher number of cells in the S phase and M phase was detected in the P15-FOXQ1 group compared with that in the P15-vector group.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 29,500,491 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
KNDC1
|
85442
|
protein coding
|
HUVEC
|
Umbilical cord
|
Aging
|
Accelerate
|
SA--gal activity assay
|
The number of positive SA-¦Â-Gal staining observed in the HUVECs following the transfection of the KNDC1?adenovirus vector significantly increased when compared with that in the control group.
|
--
|
--
|
--
|
--
|
p53
|
Upregulation
|
Western blot
|
However, a significant increase in the expression of p-p53 was observed in HUVECs that overexpressed KNDC1 when compared with the NT-adenovirus-transfected control cells.
|
Human
|
L
|
delay aging
| 29,568,929 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FOXO3
|
2309
|
protein coding
|
HUC-F2
|
--
|
Aging
|
Prevent
|
SA--gal activity assay//qRT-PCR
|
Proliferative potential and senescence-associated ¦Â-galactosidase (SA-¦Â-Gal) activity were then monitored. Our results clearly showed that the dominant Activate form of FOXO3a (FOXO3aTM) significantly promoted proliferation and inhibited the onset of replicative senescence in HUC-F2 cells in a manner similar to SIRT1 [6].We detected a significant elongation of telomere length in HUC-F2 cells transduced with FOXO3aTM.
|
c-Myc//hTERT
|
Upregulation//Upregulation
|
Luciferase reporter assay//qRT-PCR
|
We found that FOXO3a increased the promoter activity of c-MYC and the transcription of the c-MYC gene. These results suggest that FOXO3a activates c-MYC expression, which, in turn,results in enhanced quantities of c-MYC at the hTERT promoter,enhanced transcriptional activation of c-MYC and, as a consequence, upregulation of hTERT gene expression.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,000,517 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
CCN1
|
3491
|
protein coding
|
--
|
Skin
|
Aging
|
Accelerate
|
Atomic force microscopy imaging
|
This increase of CCN1 was associated with constitutively reduced type I collagen, and constitutively elevated MMP-1 in forearm chronically sun-exposed prematurely aged human skin.
|
IL-1¦Â
|
Upregulation
|
qRT-PCR//ELISA
|
Elevated expression of CCN1 in dermal fibroblasts resulted in significant upregulation of IL-1¦ÂmRNA and protein levels.Importantly, knockdown of CCN1 induction significantly reduced UV irradiation induction of IL-1¦Â mRNA and protein levels, indicating that induction of IL-1¦Â is dependent, in part, on induction of CCN1.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 23,881,607 |
Gene
| 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TRIM28
|
10155
|
protein coding
|
IMR-90
|
--
|
Aging
|
Accelerate
|
BrdU assay//Crystal violet assay//Immunostaining//Knockdown//SAHF
|
We observed that TRIM28 depletion resulted in increased cell growth upon OIS induction,similar to what was observed upon p53 knockdown.TRIM28 knockdown also resulted in less cells presenting features characteristic of senescence such as senescence-associated heterochromatic foci.A higher percentage of cells with depleted TRIM28 levels incorporated BrdU 6 days upon 4OHT induction, suggesting that depletion of TRIM28 partially prevented the effects of OIS.
|
p16
|
--
|
Immunostaining//knockdown
|
p16INK4a levels were lower upon knockdown of TRIM28.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,160,591 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ARG2
|
384
|
protein coding
|
HUVEC
|
--
|
Aging
|
Accelerate
|
SA--gal activity assay//Western blot
|
The senescence markers such as the number of SA-¦Â-gal positive cells,the levels of p53-S15 and p21Cip1 as well as levels of VCAM1 and ICAM1 are significantly augmented by Arg-II overexpression.
|
eNOS
|
--
|
Western blot//Immunostaining
|
Conversely, in nonsenescent cells, adenovirus-mediated ectopic expression of a wild-type (WT) Arg-II cDNA as verified by immunoblotting,leads to eNOS-uncoupling, i.e., impaired NO production (DAF-2DA staining) and enhanced intracellular O2-generation (DHE staining),which is significantly inhibited by the eNOS inhibitor L-NAME.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 22,928,666 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RPS6KB1
|
6198
|
protein coding
|
HUVEC
|
--
|
Aging
|
Accelerate
|
SA--gal activity assay//Western blot
|
S6K1 increases the number of positively stained SA-¦Â-gal cells, elevates p53-S15 and p21Cip1 levels, and enhances VCAM1 and ICAM1 expression, demonstrating that persistent hyperActivate S6K1 promotes endothelial senescence and inflammation.
|
Arg-II
|
Upregulation
|
qRT-PCR
|
Indeed, in young endothelial cells, overexpression of a constitutively Activate S6K1 mutant (HA-S6K1ca), but not the inActivate S6K1 mutant, which is confirmed by immunoblotting with the anti-S6K1 antibody that detects both mutants, enhances Arg-II mRNA and protein levels paralleled with increased arginase activity.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 22,928,666 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
JUND
|
3727
|
protein coding
|
Aortic endothelial cell
|
Aorta
|
Aging
|
Prevent
|
Immunostaining//Knockdown//SA--gal activity assay//Western blot//qRT-PCR
|
Telomerase activity was blunted in young JunD?/? compared with age-matched WT mouse aorta.This finding indicated a vascular senescence phenotype in young animals lacking JunD .¦Â-Galactosidase staining further supported the early occurrence of vascular aging in JunD?/? mice. Accordingly, the expression of aging markers such as tumor suppressor p53 and the cyclin-dependent kinase inhibitor p16INK4a was increased in these mice.
|
p47phox//NOX2//NOX4
|
--//--//--
|
Immunostaining//Western blot
|
In contrast,the NADPH oxidase subunits p47phox, Nox2, and Nox4 were already upregulated in young JunD?/? mice and further increased with aging.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 23,410,942 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
IGF1
|
3479
|
protein coding
|
MCF-7,IMR-90
|
--
|
Aging
|
Accelerate
|
BrdU assay//Cell morphological analysis//SA--gal activity assay
|
IGF-1 treatment of IMR90 or MEF cells led to appearance of cells with feature characteristic of premature cellular senescence, including an enlarged flat cell morphology and increased ¦Â-Galactosidase (SA-¦Â-Gal) activity.By contrast, cells treated with IGF-1 remained morphologically large and flat, with marginal BrdU incorporation .
|
--
|
--
|
--
|
--
|
SIRT1-p53
|
Activation
|
Western blot
|
IGF-1 significantly inhibited SIRT1 deacetylase activity.We confirmed comparable SIRT1 protein input levels by western blot analysis.IGF-1 treatment led to a marked increase in p53 protein levels in serum-starved MCF7, U2-OS, and IMR90 cells.IGF-1 treatment led to a substantial increase in p53 protein half-life, compared with the control.
|
Human
|
L
|
delay aging
| 25,070,626 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT6
|
51548
|
protein coding
|
HCA2
|
--
|
Aging
|
Prevent
|
Immunostaining
|
SIRT6 reduced the number of ¦ÃH2AX foci.
|
PARP1
|
--
|
Western blot//Autoradiography
|
Instead, we used the specific PARP1 inhibitor PJ34. Importantly, PJ34 had no inhibitory effect on either deacetylation or mono-ADP ribosylation activities of SIRT6.In the presence of PJ34, SIRT6 overexpression had no effect on HR,indicating that SIRT6-mediated rescue of HR in aging cells is dependent on PARP1.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 22,753,495 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT1
|
23411
|
protein coding
|
B-MSC,A-MSC
|
Bone and Adipose
|
Aging
|
Prevent
|
BrdU assay//Knockdown//PI staining//SA--gal activity assay
|
Compared to control, the knockdown of SIRT1 markedly slowed down the growth rate of both types of MSC, as shown by plotting a curve of the cell growth and by the use of a BrdU incorporation assay.In B-MSCs, SIRT1 knockdown significantly decreases the percentage of cells in S phase,while A-MSCs have significantly more cells in the G0/G1 phase and fewer cells in the S phase and G2¨CM phase after SIRT1 knockdown.However, in cells from later passages, more SA-¦Â-gal+cells were observed in those cultures where SIRT1 had been knocked down.
|
p16
|
--
|
Western blot
|
However, in late culture passages, p16 but not p21 is accumulated faster in B-MSCs where SIRT1 has been knocked down.Conversely, overexpression of SIRT1, but not its dominantnegative mutant H363Y , efficiently delayed the accumulation of p16.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 22,038,097 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PTEN
|
5728
|
protein coding
|
--
|
Human islet
|
Aging
|
Accelerate
|
Immunostaining//Knockdown
|
The percentage of Ki67 positive cells was dramatically increased in the Pten null mice that are 3 months old and older.
|
--
|
--
|
--
|
--
|
PI3K-Akt//cyclin D1-E2F-Ezh2-p16
|
Downregulation//--
|
Western blot
|
A primary biochemical function of PTEN is to inhibit the action of PI3K.We show that phosphorylation of the PI3K effector, serine/threonine kinase AKT, is dramatically induced in the Pten null islets compared with the Con ones, whereas the amount of p-ERK is minimally altered.Elevated cyclin D1 leads to the activation of E2F through phosphorylation of retinoblastoma (RB) proteins. We found that overexpression of E2F1 led to downregulation of p16ink4a expression, whereas knockdown of E2F1 robustly induced expression of p16ink4a.We found that expression of E2Fs1-4,especially E2Fs1-3, resulted in the dramatic induction of an Ezh2 promoter activity.
|
Human
|
L
|
delay aging
| 23,826,727 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RECQL4
|
9401
|
protein coding
|
Fibroblast
|
Mouse tail
|
Rothmund¨CThomson syndrome
|
Prevent
|
Immunostaining//SA--gal activity assay
|
Recql4HD fibroblasts expressed more SA-¦Â-gal than wild-type fibroblasts.In addition, the average number of 53BP1 foci was approximately threefold higher under 3%oxygen and fourfold higher under 20% oxygen in cells from old Recql4HDcells compared with cells from old wild-type cells. The average number of ¦ÃH2A.X foci per cell was two- or threefold more in Recql4HDcells than in wild-type cells.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 24,832,598 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
E2F1
|
1869
|
protein coding
|
MEF
|
Embryo
|
Aging
|
Accelerate
|
BrdU assay//Knockdown//SA--gal activity assay
|
The ability of MEFs to proliferate decreases with cell passage; knocking out E2F1 attenuates this effect. The proliferation of passage 5 WT MEFs was greatly reduced compared with E2F1 KO MEFs, with all cells visualized by Hoechst stained DNA but DNA synthesis was greatly reduced only in WT cells.by passage 5 a significantly greater proportion of WT MEFs were testing positive for senescence compared with E2F1 KO MEFs, indicated by SA-¦Â-gal activity.
|
FOXO3
|
Downregulation
|
Luciferase reporter assay//Immunostaining
|
The reporters alone show some activation of the FKRE-luciferase gene, presumably from endogenous FOXO1/3 proteins. This activation is significantly repressed when the E2F1 plasmid is co-transfected.Moreover, the levels of intracellular ROS,as measured by dichlorofluorescein (DCF) levels, whether in the steady state or under oxidative stress, were significantly reduced in E2F1 KO MEFs compared with WT cells.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 25,344,604 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
E2
|
1489080
|
protein coding
|
HeLa
|
--
|
Aging
|
Accelerate
|
Cell morphological analysis//SA--gal activity assay
|
The parental HeLa cells infected with the E2 virus expressed the expected senescent phenotype including growth arrest, increased cell size and flattening, elevated autofluorescence and high level SA-¦Â-gal activity.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 16,626,397 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IGF1
|
3479
|
protein coding
|
Myocyte
|
--
|
Cardiomyopathy and heart failure
|
Prevent
|
Telomere length assay//Western blot
|
IGF-1 interfered with the age-dependent increases in myocyte size, telomeric shortening and p16INK4aand p53 proteins.
|
--
|
--
|
--
|
--
|
PI3K-Akt
|
Activation
|
Western blot
|
Akt protein (total) remained constant and did not differ in WT and TG myocytes. However, phospho-Akt levels decreased in WT and increased in TG myocytes from 4 to 20 to 22 months.
|
Human
|
L
|
delay aging
| 14,726,476 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
UBE2I
|
7329
|
protein coding
|
U2OS
|
--
|
Aging
|
Prevent
|
Growth curve assay
|
Under senescence promoting conditions there is a clear delay for the onset ofsenescence in U2OS when cells express the wild type form of UBC9 while the K49R variant shows no effect and undergoes senescence like the control cells.
|
PML
|
Binding
|
Growth curve assay
|
As expected, both Ubc9-PML and Ubc9K49R-PML fusion proteins localized to nuclear bodies.Expressing either Ubc9-PML or Ubc9K49R-PML fusion proteins counteracted the senescence induced by PML as compared to GFP-PML fusion in control cells .
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 29,773,808 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HGF
|
3082
|
protein coding
|
hE-MSC,BM-MSC
|
--
|
Liver disease
|
Prevent
|
FISH//qRT-PCR
|
RTL was analyzed after treating hE-MSCs with a neutralizing HGF antibody.Telomere length was decreased to 50% and PDT was delayed to 80 hr upon loss of HGF function in hE-MSCs.Interphase telomere fluorescence in situ hybridization (FISH) showed that treatment of hBM-MSCs with rHGF increased the number and intensity of PNA foci in the nucleus.After normalization to AIB1, a reference gene with only a single copy on the chromosome, the relative mtDNA copy number was 1.5-fold higher in rHGF-treated cells than in control cells.
|
RAD51
|
Upregulation
|
HR assay//Western blot
|
When we treated hBM-MSCs with rHGF, the activity and protein level of RAD51 increased.When we blocked HGF in hE-MSCs using a neutralizing antibody,the protein level of RAD51 decreased.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 29,398,486 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MCL1
|
4170
|
protein coding
|
HCT116
|
--
|
Colorectal cancer
|
Prevent
|
Immunostaining
|
Impressively, DPI (similar to NAC) caused a robust abrogation of ROS generation in Mcl-1 deficient cells as compared with the Mcl-1 proficient cells during CIS conditions after 24 hours of culture with doxorubicin, a time point that significant differences in ROS production can be observed.
|
NOX4
|
Downregulation
|
Western blot//Co-IP
|
Immunoblot analysis using NOX4 specific antibody shows that NOX4 is predominantly up regulated in the mitochondrial fraction in CIS-sensitive cells under doxorubicin treatment in the absence of Mcl-1.Mcl-1 has a unique ability to inhibit ROS production by preventing the up regulation of the pro-oxidant NOX4.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 28,423,654 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MAPK1
|
5594
|
protein coding
|
Fibroblast
|
--
|
Prostate cancer
|
Accelerate
|
Knockdown//SA--gal activity assay//Western blot
|
ERK2 knockdown in cells expressing RasV12 inhibited the induction of senescence-associated ¦Â-galactosidase (SA-¦Â-Gal), PML bodies, and DNA damage foci.Oncogenic ras engaged the p53/p21, p16INK4a/RB, and p38MAPK pathways in primary cells, and this was efficiently prevented by knockdown of ERK2.The induction of several senescence-associated cytokine genes by RasV12 was also efficiently blocked by ERK2 knockdown.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 23,599,344 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SOD2
|
6648
|
protein coding
|
Chondrocyte
|
Bone
|
Cartilage degeneration
|
Prevent
|
Flow cytometry//Safranin O/Fast Green staining
|
Histological analyses by the OARSI score revealed that Sod2 cKO joints exhibited a significant loss of safranin-O staining in all layers of both articular cartilages in Sod2 cKO mice.The control joint showed the loss of safranin-O staining without morphological changes in the superficial layer of MFC and MTP .Sod2 cKO chondrocytes demonstrated significantly increased superoxide generation via flow cytometry with DHE and MitoSOX stainings.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 26,108,578 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LMNA
|
4000
|
protein coding
|
--
|
Embryo
|
Aging
|
Prevent
|
SA--gal activity assay
|
The zLMNA-MO2 morphants showed a high intensity of SA-¦Â-gal at 6 dpf, whereas zLMNA-MO1 morphants did not show significantly detectable SA-¦Â-gal activity.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 21,479,207 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SOD3
|
6649
|
protein coding
|
Fibroblast
|
Skin
|
Aging
|
Prevent
|
Survival curve
|
SOD3R213G Tg mice exhibited a shortened life span with their hair turning gray upon aging.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
HL
|
delay aging
| 25,927,599 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DKC1
|
1736
|
protein coding
|
MEF
|
Embryo
|
X-linked dyskeratosis congenita
|
Prevent
|
Flow cytometry//Lifespan assay//SA--gal activity assay
|
In 3% oxygen, ¡÷15 cells grew more slowly and entered senescence earlier than WT cells.¡÷15 cells accumulated more ROS than WT cells and the difference became very significant with more PDs, even when cell .There was a significantly higher number of foci in D15 cells, and the difference was greater in high oxygen.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 21,241,452 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IRS2
|
8660
|
protein coding
|
Astrocyte
|
Brain
|
Huntington disease
|
Accelerate
|
Survival curve
|
The body weights of R6/2?Irs2ntg mice increased normally until 7 weeks, but afterward declined rapidly, and half the mice died between 11 and 12 weeks of age. Based on Cox regression,neuronal Irs2 in R6/2?Irs2ntg mice significantly increased the risk of death 3.6-fold compared with R6/2 mice;sex of the mice was not a significant covariate.The fore limb grip of R6/2 and R6/2?Irs2ntg mice was significantly weaker than those of control and R6/2?Irs2+/¨C?Irs2¦Âtg mice.
|
FOXO1
|
--
|
Western blot
|
The fractionation of brain homogenates and immunoblotting confirmed that phosphorylated FoxO1 was largely cytoplasmic in R6/2 and R6/2?Irs2ntg mice, whereas FoxO1 was weakly phosphorylated and most strongly detected in the nuclear (laminin-containing) fractions from R6/2?Irs2+/¨C?Irs2¦Âtg brains.
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 21,926,467 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TP53
|
7157
|
protein coding
|
MEF
|
--
|
Tumor
|
Accelerate
|
Cell morphological analysis//SA--gal activity assay
|
The shorter survival of nontumor-bearing p53S18Amice suggests that their aging process could be accelerated due to the Ser18mutation. In fact, these mice exhibited heightened expression of several factors associated with aging, such as inability to heal, premature graying, chronic alopecia, and lordokyphosis. The number of positive blue cells increased with each passage of p53S18A cells, compared with wild-type cells. By passage 3,30% of p53S18A cells stained positive for ¦Â-gal, whereas none of the wild-type cells stained positive . Also, the cells seemed to be mostly large flat cells, which is consistent with cells having exited the cell cycle.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
delay aging
| 18,089,799 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ING1
|
3621
|
protein coding
|
Hs68
|
--
|
Aging
|
Accelerate
|
DAPI staining//Flow cytometry//SA--gal activity assay
|
The occurrence of SAHF in senescent cell nuclei (panel B) and highlights the similarity of nuclear phenotype and DNA staining patterns between senescent cells and cells expressing high levels of INGla.Examining the effect of ING1a on cell cycle distribution showed that overexpression of INGla induced cell cycle arrest increased progressively with time despite culturing in complete medium and the percentage of primary Hs68 cells in the G1 phase.Expression of ING1a efficiently induced the expression of SA-¦Â-gal activity.In contrast, cells overexpressing INGla acquired a senescent-like flattened phenotype and a DNA staining pattern similar to that seen in SAHF.
|
--
|
--
|
--
|
--
|
p16-pRb
|
Activation
|
Western blot
|
ING1a expression substantially increased both pl6 and pRb levels.
|
Human
|
L
|
apoptosis
| 18,691,180 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PTEN
|
5728
|
protein coding
|
BM-MSC
|
--
|
Systemic Lupus Erythematosus
|
Accelerate
|
Flow cytometry//Knockdown//SA--gal activity assay
|
There were less SA-¦Â-gal-positive cells when PTEN expression was knocked down in BM-MSCs from SLE patients, but it has less effect in the control group¡¯s BM-MSCs. The further quantitative analysis indicated the number of SLE patients¡¯ BM-MSCs increased in si-PTEN-transfected group compared to the untreated group from the third day .Cell-cycle analysis revealed that G1 phase arrest was observably reversed in si-PTEN-transfected SLE BM-MSCs.
|
--
|
--
|
--
|
--
|
p27
|
Upregulation
|
Western blot//Immunofluorescence
|
In the BM-MSCs from SLE patients, we found that the expression of PTEN was up-regulated, and the phosphorylation of Akt was reduced. Meanwhile, the higher expression of PTEN and the lower expression of p-Akt in SLE BM-MSCs were confirmed by immunofluorescence. The expression of cell-cycle regulator p27kip1 was determined. The results showed that p27kip1 increased markedly in BM-MSCs from SLE patients and nuclear fluorescence intensity was enhanced. The expression of p27kip1 decreased significantly in SLE BM-MSCs transfected with si-PTEN .
|
Human
|
L
|
apoptosis
| 25,649,549 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BTK
|
695
|
protein coding
|
EJp53,HDF
|
--
|
Aging
|
Accelerate
|
Growth curve assay//SA--gal activity assay
|
Inhibition of BTK by chemical or genetic approaches increased cell proliferation in EJp53 induced to senesce. Indeed, the percentage of cells positive for senescence associated (SA)-¦Â-gal, a widely used marker of senescence (32), was significantly lower when BTK was inhibited, and less cells showed the morphological changes typical of senescence.
|
--
|
--
|
--
|
--
|
p53
|
Activation
|
Western blot//RT-PCR
|
We found that BTK protein levels were elevated after inducing p53 expression in these cells. Moreover, the colon cancer cell line HCT116, which has wild-type p53, also showed a p53-dependent BTK induction after being treated with DNA damaging agents (the oxidant tBH and doxorubicin), both at protein and mRNA levels. We transfected BTK into EJp53 and observed that it elevated the levels of p53 protein induced by tet removal.
|
Human
|
L
|
apoptosis
| 27,630,139 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
KRT24
|
192666
|
protein coding
|
Primary human epidermal keratinocyte
|
Skin
|
Aging
|
Accelerate
|
EdU Assay//Flow cytometry//MTS assay//SA--gal activity assay
|
The results indicated that K24 overexpressed keratinocytes showed decreased proliferation rate, as compared with control cells. Furthermore, the actual proliferative capacity of the K24 overexpressed keratinocytes was then determined by EdU assay. The percentage of proliferating cells from the K24 overexpressed cells was 43% after 72 h of incubation, whereas 78% being detected for the control cells.The result showed that the transfection of K24 decreased the DNA synthesis and induced a G1/S growth phase arrest, as evidenced by 84.09% in the experimental group, and 63.94% in the vector control cells. SA-¦Â-galactosidase staining showed a 3-folds more positive blue cells in K24 overexpressed keratinocytes than those in control cells .
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
apoptosis
| 28,362,807 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DLK1
|
8788
|
protein coding
|
WI-38
|
--
|
Aging
|
Prevent
|
Flow cytometry//Knockdown//SA--gal activity assay
|
Cells infected with the Sh-hDLK2 lentiviral construct exhibited a significantly slower rate of proliferation when compared to control cells,suggesting that depletion of DLK inhibited cell proliferation.Our results showed that loss of DLK results in a diminution of cells in S phase, an increased proportion (¡«20%) of cells in G1 phase and an unchanged percent-age of cells in the G2/M phase.More than 70% of cells infected with the lentivirus expressing a human DLK shRNA (Sh-hDLK2) showed elevated SA-¦Â-Gal activity, whereas control cells failed to exhibit ¦Â-Gal staining.
|
--
|
--
|
--
|
--
|
ERK//p53-p21
|
--//--
|
Western blot//Knockdown
|
In DLK-depleted cells, we noted a substantial decrease in ERK phosphorylation level relative to control , indicating that ERK activity in WI-38 cells is dependent on DLK. we observed that p53 and p21 expression was significantly up-regulated in DLK-depleted cells as compared to cells infected with the control lentiviruses.
|
Human
|
L
|
apoptosis
| 21,893,036 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SAE2
|
816686
|
protein coding
|
HCT116,U2OS
|
--
|
Cancer
|
Prevent
|
BrdU assay//Flow cytometry//Knockdown//PI staining//SA--gal activity assay
|
SAE2 and UBC9 shRNAs (sh1 and sh2) potently blocked colony formation in vitro.By PI staining and flow cytometry, we observed increased sub-G1 cell population in HCT116 cells upon conditional SAE2 knockdown , suggesting some cells are undergoing apoptosis.By BrdU incorporation assay, we observed a decreased percentage of cells in S phase in SAE2 knockdown U2OS cells.SAE2 knockdown HCT116 cells also showed a multi-nucleated phenotype with enlarged and flattened morphology which is commonly observed in senescent cells. This cell population stained positive for SA-¦Â-Gal activity.
|
--
|
--
|
--
|
--
|
SUMO
|
Activation
|
SA-¦Â-gal activity assay//Flow cytometry//DAPI staining//Western blot
|
As further confirmation that the non-silencible SAE2 can functionally rescue the SUMO pathway activity, we performed the same sub-G1 apoptosis assay and SA-¦Â-Gal staining. The wildtype SAE2, but not the C->A enzyme dead SAE2 mutant, partially rescued shSAE2 induced multinucleation and senescence,and associated cell death.SUMO substrate and SUMOylation is important for TopoII¦Á activity in vitro [35¨C37]. Western blots in HCT116 cells expressing control or SAE2 shRNA revealed endogenously SUMOylated TopoII¦Á species, and knockdown of SAE2 inhibited TopoII¦Á SUMOylation.
|
Human
|
L
|
apoptosis
| 25,860,128 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IFNG
|
3458
|
protein coding
|
Melanocyte
|
--
|
Vitiligo
|
Accelerate
|
Flow cytometry//SA--gal activity assay
|
IFN-¦Ã significantly decreased the cell viability in a dose dependent manner. Cell cycle analysis results demonstrated that IFN-c at both concentrations caused the accumulation of melanocytes at G1 phase, while decreased the percentage of cells at S and G2/M phases.In contrast, melanocytes after persistent IFN-¦Ã treatment became large, flat in shape with shorter and fewer dendrites, and some cells were highly pigmented.We also noticed a significantincrease of SA-¦Â-gal stain ing, a marker of senescence, in melanocytes with 7 days of IFN-¦Ã stimulation.
|
p21/WAF1
|
Upregulation
|
Western blot//SA-¦Â-gal activity assay
|
Immunoblotting analysis indicated that protein level of p21 was greatly elevated with the increasing duration of IFN-¦Ã treatment,while p16 level didn¡¯t change during the experiment.P21 siRNA treatment suppressed the IFN-¦Ã-induced increase of SA-¦Â-gal staining.
|
JAK2-STAT1
|
--
|
MTS assay//Western blot//SA-¦Â-gal activity assay//Flow cytometry
|
In the presence of IFN-¦Ã, the cell viability of control siRNA transfected melanocytes was significantly inhibited. Significantly, JAK2 or STAT1 siRNA efficiently restored the viability of melanocytes. Immunoblotting results confirmed that JAK2 or STAT1 siRNA, but not JAK1 siRNA inhibited the increase of p21 induced by IFN-. Moreover, IFN-¦Ã-induced SA-¦Â-gal staining increase in melanocytes was blocked by JAK2 and STAT1 siRNAs.IFN-¦Ã treatment caused obvious elevation of intracellular ROS, and the effect of IFN-¦Ã was dose-dependent manner.
|
Human
|
L
|
apoptosis
| 24,681,574 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CTSK
|
1513
|
protein coding
|
MEF,NHDF
|
--
|
Aging
|
Prevent
|
BrdU assay//Cell morphological analysis//SA--gal activity assay
|
NHDF lacking cathepsin X exhibited a flattened cell body and a significant increase in size in comparison to control cells expressing normal amounts of cathepsin X. Quantification of SA-¦Â-gal in NHDF lacking cathepsin X clearly demonstrated a significant increase both in the number of stained cells and in the intensity of staining .Cathepsin X-deficient MEF displayed a reduced cell growth when assayed by two different cell proliferation assays employing different DNA labeling techniques. The number of BrdU(+) cells which had gone through cell division (2 N DNA content) was significantly lower 24h after the pulse in cells lacking cathepsin X indicating a delayed G1 entry.
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
Human
|
L
|
apoptosis
| 21,616,554 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MDM2
|
4193
|
protein coding
|
H460
|
--
|
Lung cancer
|
Prevent
|
Flow cytometry//SA--gal activity assay
|
Missense oligonucleotide alone caused apoptosis in 5.6 ¡À 0.6% (mean F SD) cells and radiation treatment increased this to 16 ¡À 1.3%. The anti-MDM2 oligonucleotide alone had a greater effect than the missense oligonucleotide with 18 ¡À 0.2% apoptotic cells.Missense oligonucleotide caused 2.7¡À0.2% and 7.0 ¡À 0.6% (mean ¡À SD) of senescent cells at 0 and 5 Gy, whereas anti-MDM2 ¨Ctreated cells showed significantly greater senescence with 5.3 ¡À 0.4% and 42.7 ¡À 1.5% (P < 0.001 missense compared with anti-MDM2 oligonucleotide).
|
p53//p21
|
Upregulation//Upregulation
|
Western blot
|
H460 cells pretreated with missense ASODN followed by 5 Gy showed an increase in MDM2,p53, and p21 expression at 24 hours, compared with H460 treated with missense ASODN alone.
|
--
|
--
|
--
|
--
|
Human
|
L
|
apoptosis
| 16,093,429 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDKN1C
|
1028
|
protein coding
|
HepG2,SNU398 HCC
|
--
|
Hepatocellular carcinoma
|
Accelerate
|
Cell morphological analysis//Flow cytometry//SA--gal activity assay//Western blot
|
Induction of P57 reduced proliferation of HepG2 and SNU398 HCC cells, as demonstrated by growth curve analysis.FACS analysis revealed that P57 transfected cells accumulate in G1 phase of cell cycle. Seventy-two hours post-P57 transfection, cells began to change the morphology, becoming enlarged and flattened, and they adopted a senescent phenotype when compared to vector-only cells .In accordance with the senescence phenotype, induction of P57 in HepG2 and SNU398 led to the identification SA-¦Â-gal positive cells.An increase in P16 protein levels was also observed in HepG2 cells.
|
--
|
--
|
--
|
--
|
Hes1
|
--
|
RT-PCR//Western blot
|
Notch3-and Notch1-silenced cells showed a down-regulation of Hes1 target gene together with an up regulation of P57 mRNA and protein levels .Down-regulation of Hes1 significantly increased P57 mRNA and protein levels in both analyzed cell lines .In HepG2 cells, but not in HepG2, with siRNA to Hes1, DNA of the P57 promoter region could be specifically detected in the Hes1-immunoprecipitated DNA complex from formaldehyde-treated cells, indicating Hes1 occupancy at the P57 promoter in vivo.
|
Human
|
L
|
apoptosis
| 22,705,236 |
Gene
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.